Related Experiment Video
Updated: Aug 30, 2026

Nanosensors to Detect Protease Activity In Vivo for Noninvasive Diagnostics
Published on: July 16, 2018
Fluorescent iron-doped polymer dot nanozyme-based cascade reaction for α-glucosidase activity and inhibitor detection
Zongcheng Zhang1, Yu Wang1, Feifei Wang1
1College of Pharmacy, Xinjiang Key Laboratory of Biopharmaceuticals and Medical Devices, Institute of Materia Medica, Xinjiang Medical University, Urumqi 830017, China.
Abstract:
The accurate quantification of α-glucosidase (α-Glu) activity and its inhibitor is of vital for diabetes diagnosis and drug screening. Enzyme activity could be detected by developing a sensing method based on nanozyme-involved cascade reaction. However, such a cascade reaction typically produces only one signal, whereas the fabrication of multifunctional nanozymes toward this end remains a formidable challenge. Herein, iron-doped fluorescent polymer dots (Fe-PDs) were one-pot synthesized under mild conditions. Iron doping accelerates PDs formation and imparts prominent peroxidase (POD)-like activity to the material. The as-prepared Fe-PDs could catalyze the oxidation of colorless TMB by H2O2 to form chromogenic oxTMB, which quenched the intrinsic fluorescence of Fe-PDs via the inner filter effect (IFE). Relying on three-catalyst cascade catalysis of α-Glu, glucose oxidase (GOx) and POD, this work constructed a highly sensitive colorimetric-fluorescent sensing platform. By introducing p-nitrophenyl-α-D-glucopyranoside (PNPG) as the substrate, the system enables quantitative analysis of H2O2, glucose, α-Glu activity as well as α-Glu inhibitors. Benefiting from cascade-induced signal amplification, the dual-modal assay enables quantitative analysis of α-Glu activity with linear ranges of 0.2-20 mU/mL (colorimetry) and 0.2-25 mU/mL (fluorometry), and detection limits of 0.10 and 0.094 mU/mL, respectively. Furthermore, this assay enables the screening of α-Glu inhibitors (AGIs) and determination of AGIs in real samples, which shows satisfactory consistency compared with the traditional PNPG assay, demonstrating the great application prospects for clinical diagnosis and anti-diabetic drug discovery.

